Paragon Therapeutics, Inc.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
Philadelphia, PA
CIK
0001861055
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
Damora Therapeutics, Inc. 13G/A
DMRA · 36322Q206
3.4% 4/23/2026
Event 2/9/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.